Zydus Lifesciences Ltd (BOM:532321)
₹ 964.4 -8.55 (-0.88%) Market Cap: 970.41 Bil Enterprise Value: 965.67 Bil PE Ratio: 22.61 PB Ratio: 4.45 GF Score: 97/100

Cadila Healthcare Ltd to Discuss About the Emergency Use Authorization of ZyCov-D Vaccine Call Transcript

Aug 23, 2021 / 09:30AM GMT
Release Date Price: ₹547.05 (+2.21%)
Operator

Ladies and gentlemen, good day, and welcome to the tele-call of Cadila Healthcare Limited, which is scheduled to discuss the ZyCoV-D vaccine which has recently been granted an emergency use approval by DCGI. (Operator Instructions) Please note that this conference is being recorded. I now hand the conference over to Mr. Vishal Gor, Senior Vice President from Corporate Finance team of Cadila Healthcare Limited. Thank you, and over to you, Mr. Gor.

Vishal Gor;SVP Corporate Finance

Thank you. Good afternoon, ladies and gentlemen, and welcome to the Cadila Healthcare Limited teleconference to discuss on ZyCoV-D vaccine, which has recently been granted the emergency use approval from DCGI. For today's call, we have Dr. Sharvil Patel, Managing Directorate of Zydus Cadila; and Mr. Alok Garg, Senior Vice President from MD's office. This call is only to discuss the ZyCoV-D vaccine opportunity. And if you have any other questions on any other businesses, kindly reach out to us separately, and we shall be happy to address the same at the earliest.

With

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot